New York Festivals Advertising Awards Announces Milestone Win; Names Klick Health ‘Agency of the Year'
Scott Rose, New York Festivals Advertising Awards President said, 'We're thrilled to celebrate Klick Health's extraordinary success in the 2025 NYFA. This marks the first time a health agency has earned the prestigious title of Agency of the Year, a milestone that speaks to the power of Klick's innovative and purpose-driven creativity. Among their many award-winning campaigns, the Grand Award-winning '47' stands out as a powerful testament to inclusion, resilience, and the transformative impact of storytelling.'
'We are incredibly proud to be recognized among the world's top agencies by the NYFA,' said Klick Health Chief Creative Officer Rich Levy. 'As the first health-focused agency to be named Agency of the Year, it's inspiring to see creativity in health continue to take its place on the global stage and a testament to the quality of work being done throughout the healthcare industry.'
With entries from six continents judged by an international jury of more than 350 members, the NYFA jury pushed forward work that puts brands in the spotlight and resonates with today's consumers. Among the top accolades, Klick received the Grand Award in Film Craft, eight Gold Towers, four Silver Towers, and four Bronze Towers for its ' 47,' ' American Cancer Story,' and ' Voice 2 Diabetes ' campaigns.
Klick's full list of New York Festivals Advertising Awards
AGENCY OF THE YEAR
GRAND AWARD: 47 – Café Joyeux – Film Craft - Animation
GOLD: 47 – Café Joyeux – Film Craft - Animation
GOLD: 47 – Café Joyeux – Film Craft - Best Use of Music
GOLD: 47 – Café Joyeux – Film Craft - Production Accomplishment
GOLD: 47 – Café Joyeux – Design - Best Use: Art Direction/Production Design
GOLD: 47 – Café Joyeux – Design - Best Use: Custom Illustration
GOLD: Voice 2 Diabetes – KVI Brave Fund Inc. – Avant-Garde/Innovative: Technology
GOLD: Voice 2 Diabetes – KVI Brave Fund Inc. – Best Use: Technology
GOLD: Voice 2 Diabetes – KVI Brave Fund Inc. – Best Use: Use of Data
SILVER: 47 – Café Joyeux – Design - Branded Content/Entertainment: Craft: Production Accomplishment
SILVER: Voice 2 Diabetes – KVI Brave Fund Inc. – Best Use: Innovation
SILVER: Voice 2 Diabetes – KVI Brave Fund Inc. – Purpose: Technology for Good
SILVER: Voice 2 Diabetes – KVI Brave Fund Inc. – Digital/Mobile: Best Use: Voice Activation
BRONZE: American Cancer Story – Change the Ref – Film: Best Use: Social/Environmental Good: NGO/PSA
BRONZE: 47 – Café Joyeux – Film Craft: Art Direction/Production Design
BRONZE: 47 – Café Joyeux – Purpose: Children - Health, Happiness and Safety
BRONZE: Voice 2 Diabetes – KVI Brave Fund Inc. – The Future Now: Effectiveness: Use of AI for Effectiveness
About Klick Health
Klick Health is the world's largest independent commercialization partner for life sciences, focused on hacking the boundaries of health by developing, launching, and supporting life sciences brands to achieve their full potential. The agency provides best-in-class marketing and advertising, media strategy and purchasing, medical affairs and medical communications, value and market access services, as well as enterprise omnichannel enablement among its specialized offerings. Klick's client service is rooted in deep medical and scientific understanding, enabled by nearly 250 post-graduate, in-house medical experts; unrivaled decision sciences capabilities; and innovative, results-driven creative.
One of the most-awarded advertising agencies on the planet, Klick was named 2024 Clio Health Independent Agency of the Year, London International Awards Global (and Regional) Independent Health & Pharma Agency of the Year, as well as Cannes Lions #2 Healthcare Agency and #2 Healthcare Network for the second year running. Cannes Lions also recognized Klick as the 2024 #3 Independent Agency of the Year. In 2024, Klick won over 140 top creative honors, including the coveted Cannes Lions Innovation Grand Prix, and eight agency distinctions from the most respected advertising awards shows. Klick has also been ranked a Best Managed Company, Great Place to Work, Best Workplace for Women, Best Workplace for Inclusion, Best Workplace for Professional Services, Most Admired Corporate Culture, and a FORTUNE Best Workplace in Advertising.
Established in 1997, Klick Health (including Klick Katalyst and btwelve) has offices in New York, Philadelphia, Saratoga Springs, Toronto, London, São Paulo, and Singapore. It is part of the Klick Group of companies, which also includes Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
02-07-2025
- Yahoo
Boeing (NYSE:BA) Advances Space Connectivity And Strengthens Defense Leadership With New CEO
Boeing has recently seen significant events that align with a 24% price increase over the last quarter. The company completed the delivery of O3b mPOWER satellites, enhancing its connectivity solutions, and appointed Stephen Parker as president and CEO of its Defense, Space & Security division, which showed operational recovery. In the broader market, indices like the S&P 500 and Nasdaq have also seen upbeat performance, with a rise of 14% over the year. These developments likely provided additional momentum to Boeing's price movements, amidst an overall positive market trend. You should learn about the 3 risks we've spotted with Boeing (including 1 which is potentially serious). Find companies with promising cash flow potential yet trading below their fair value. The recent developments at Boeing, including the delivery of O3b mPOWER satellites and the appointment of Stephen Parker, hold significant implications for the company's strategic path. These events may bolster Boeing's growth narrative by potentially stabilizing production rates for its commercial jets, while also strengthening its position in the defense sector through leadership changes. These moves could increase investor confidence in Boeing's capacity for revenue recovery amidst ongoing challenges in tariffs, supply chains, and certification delays. In the past three years, Boeing's total shareholder return has been 52.35%. This context highlights a robust long-term performance relative to recent market movements. Over the past year, however, Boeing underperformed the US Aerospace & Defense industry, which achieved a return of 43.8%. Yet, it matched the US market return of 13.9% in the same period, illustrating a complex performance landscape. The impact of recent news on Boeing's revenue and earnings forecasts is likely positive. Increased production rates promise a stronger revenue stream supported by a substantial backlog. Additionally, the divestiture of Digital Aviation Solutions is expected to enhance cash flows, potentially reducing the negative earnings of US$11.65 billion. Furthermore, winning the F-47 fighter jet contract could provide a stable revenue flow in the defense division. Despite a 24% quarterly share price increase, Boeing's current price of US$200.26 is still below the consensus analyst price target of US$219.47, with an 8.8% growth potential implied by this target. Analysts' expectations for revenue of US$111.8 billion and earnings of US$6.5 billion by 2028 underline a belief in Boeing's recovery trajectory, albeit amid varying analyst projections and market uncertainties. Take a closer look at Boeing's potential here in our financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:BA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
New York Post
02-07-2025
- New York Post
White House denies Mark Zuckerberg was ‘asked to leave' Oval Office meeting about F-47 fighter jet
A Trump official denied a report that Meta boss Mark Zuckerberg was kicked out of the Oval Office after crashing a meeting about the futuristic F-47 stealth fighter jet. The report that Zuckerberg was 'asked to leave' the president's office during a White House visit last winter surfaced Wednesday in a lengthy NBC News report about the inner workings of President Trump's West Wing. The report, which cited two unnamed sources, said Trump was meeting in the Oval Office with military leaders about the F-47 when the Facebook founder 'walked in unexpectedly.' Officialls allegedly asked Zuckerberg to wait outside due to concerns he didn't have security clearance. Advertisement 4 A Trump official denied that Zuckerberg was asked to leave the Oval Office. Getty Images However, a senior White House official told The Post that the report had 'mischaracterized' the situation. 'He was not asked to leave,' the official said. 'He popped in to say hello at the president's request, and then left to wait for his meeting with POTUS to begin, which was scheduled to occur after the meeting with the pilots.' Advertisement Meta declined to comment. The sources who spoke to NBC News said officials involved in the meeting 'came away mystified and a bit unnerved' by the loose environment. One person reportedly described the fighter jet meeting as 'bizarro world.' 4 Mark Zuckerberg attended President Trump's inauguration in January. POOL/AFP via Getty Images As The Post has reported, Zuckerberg has faced widespread scrutiny in recent months over his attempts to cozy up with his onetime foe Trump following his win in the 2024 presidential election. He was one of several Big Tech CEOs seated front and center at Trump's inauguration in January. Advertisement Aside from personally visiting the White House on multiple occasions, Zuckerberg has taken steps at Meta that are seen as favorable to conservatives, such as ending the social media firm's fact-checking efforts and naming Trump ally and UFC President Dana White to his board of directors. Last month, The Post reported that polling data showed Americans are widely distrustful of efforts by Zuckerberg and other Big Tech executives to suck up to the president. 4 An NBC News report detailed the inner workings of President Trump's Oval Office. AP Zuckerberg was deemed the most unlikeable Big Tech CEO, with 63% of Trump voters stating they had an unfavorable view of him, according to a survey conducted by the watchdog group Tech Oversight Project and Public Policy Polling. Advertisement The NBC News report said that Trump's key Cabinet secretaries are a fixture in the West Wing and frequently visit with his closest advisers, including chief of staff Susie Wiles and deputy chief Stephen Miller. Trump reportedly affectionately refers to Wiles as the 'Ice Maiden,' with former House Speaker Newt Gingrich telling the outlet that she attends 'virtually every meeting that matters.' 4 Mark Zuckerberg has cozied up to Trump in recent months. AFP via Getty Images 'President Trump has assembled the greatest cabinet in American history—a group of talented individuals who embody the diverse coalition that delivered his historic election victory,' White House deputy chief of staff Taylor Budowich said in a statement in response to the report. 'Cabinet Member and White House Chief of Staff, Susie Wiles, has played an integral role in operationalizing his agenda through his administration and has ensured everyone is empowered with the tools to deliver on the president's mandate,' Budowich added.
Axios
02-07-2025
- Axios
Trump administration shelves Navy's F/A-XX, citing industry strain
The Trump administration is icing the U.S. Navy's F/A-XX futuristic fighter in favor of the Air Force counterpart, the F-47, amid concerns U.S. defense contractors can't handle both. Why it matters: The highly secretive project has for months been in limbo. An F/A-XX contract announcement was supposed to quickly follow F-47 news, according to Reuters, but never materialized. Driving the news: Officials at the Pentagon told reporters the fiscal 2026 budget blueprint includes $74 million to finish design of the Navy warplane. They also said there is debate at the highest levels about its future. "We did make a strategic decision to go all-in on F-47, with a $3.4 billion request for that program, due to our belief that the industrial base can only handle going fast on one program at this time and the presidential priority [is] to go all-in on that F-47 and get that program right," one official said. Catch up quick: Boeing and Northrop Grumman are in the running for F/A-XX. The former bested Lockheed Martin in March for the multibillion-dollar F-47 contract, via the Next Generation Air Dominance effort. Friction point: Boeing executives pushed back on the narrative that it — and others — can't juggle. "From day one, capital investment was for both programs. We've done the same with our technology. We've done the same with our staffing," Steve Parker, the CEO of Boeing's defense business, told reporters at the Paris Air Show. "Absolutely, we can do it. And so can the industrial base. And so can the engine manufacturers. I don't really see that as being an issue." What we're watching: The Navy could end up with a tailored version of the F-47 instead.
